Investing.com – Bristol-Myers Squibb (NYSE: ) reported third quarter EPS of $1.80, $0.30 higher than the analyst estimate of $1.50. Income for the quarter got here in at $11.9B versus the consensus estimate of $11.26B.

Steerage

Bristol-Myers Squibb sees FY 2024 EPS of $0.75-$0.95 versus the analyst consensus of $0.71.

Bristol-Myers Squibb’s inventory worth closed at $52.66. It’s up 7.98% within the final 3 months and up 2.69% within the final 12 months.

Bristol-Myers Squibb noticed 1 optimistic EPS revisions and 17 adverse EPS revisions within the final 90 days. See Bristol-Myers Squibb’s inventory worth’s previous reactions to earnings right here.

Based on InvestingPro, Bristol-Myers Squibb’s Monetary Well being rating is “good efficiency”.

Take a look at Bristol-Myers Squibb’s , and Bristol-Myers Squibb’s financials right here.

Keep up-to-date on the entire upcoming earnings stories by visiting Investing.com’s earnings calendar





Source link

Previous articleLSEG Threat Intelligence Launches New Safety Options to Mitigate World Funds and Id Threat
Next articleIndian banks’ mortgage development moderates in September amid cenbank clampdown, information reveals

LEAVE A REPLY

Please enter your comment!
Please enter your name here